"Dot COM", a nuclear transit center for the primary piRNA pathway in Drosophila

PLoS One. 2013 Sep 9;8(9):e72752. doi: 10.1371/journal.pone.0072752. eCollection 2013.

Abstract

The piRNA pathway protects genomes by silencing mobile elements. Despite advances in understanding the processing events that generate piRNAs for silencing, little is known about how primary transcripts are transported from their genomic clusters to their processing centers. Using a model of the Drosophila COM/flamenco locus in ovarian somatic cells, we identified a prominent nuclear structure called Dot COM, which is enriched in long transcripts from piRNA clusters but located far from their transcription sites. Remarkably, transcripts from multiple clusters accumulate at Dot COM, which is often juxtaposed with Yb-bodies, the cytoplasmic processing centers for cluster transcripts. Genetic evidence suggests that the accumulation of precursor transcripts at Dot COM represents one of the most upstream events in the piRNA pathway. Our results provide new insights into the initial steps of the piRNA pathway, and open up a new research area important for a complete understanding of this conserved pathway.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Nucleus / metabolism*
  • Cytoplasm / genetics
  • Cytoplasm / metabolism
  • Drosophila / genetics*
  • Drosophila / metabolism*
  • Female
  • Genetic Loci
  • Multigene Family
  • Ovarian Follicle / cytology
  • Ovarian Follicle / metabolism
  • RNA Transport
  • RNA, Small Interfering / genetics*
  • RNA, Small Interfering / metabolism*
  • Transcription, Genetic

Substances

  • RNA, Small Interfering

Grants and funding

This work was supported by grants from the Association pour la Recherche contre le Cancer (ARC 1139) and Ligue contre le Cancer. CD, VZ and EB received a grant from the Région Auvergne and European Union (EU). Research in YSR's laboratory is supported by the Intramural Research Program of the National Cancer Institute, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.